Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Trivano
Alles over “Medische Specialiteiten”
Aandelen in “Medische Specialiteiten”
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Aandeel
Datum
Koers
Evolutie
Koninklijke Philips NV
31/05
27,140 USD
-0,80%
-0,80%
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Nieuws over “Medische Specialiteiten”
Toon enkel gratis nieuws
2/06 ·
Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma
· Persbericht
2/06 ·
Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma
· Persbericht
1/06 ·
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
· Persbericht
31/05 ·
INOVIO Reports Inducement Grants Under Inducement Plan
· Persbericht
31/05 ·
QDEL Investors Have Opportunity to Lead QuidelOrtho Corporation Securities Fraud Lawsuit
· Persbericht
31/05 ·
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of QuidelOrtho
· Persbericht
31/05 ·
Beursnieuws België en Nederland
· Bolero.be
DSM Firmenich optimaliseert de financieringsstructuur Het Zwitsers-Nederlands bedrijf en producent van voedingsstoffen, smaken en geuren meldt een optimalisering van de financieringsstructuur. Het gaat om een kruislingse...
31/05 ·
Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
· Persbericht
30/05 ·
Neogen® to Participate in the 44th Annual William Blair Growth Stock Conference
· Persbericht
30/05 ·
Partnership with Key Opinion Leaders and successful trainings
· Persbericht
30/05 ·
EssilorLuxottica: Result of the payment of dividends in shares and record of the corresponding capital increase
· Persbericht
30/05 ·
Philips celebrates 1.9m liters of helium saved as it marks 1,111 helium-free MRI operations installs, expanding care to more patients in more locations
· Persbericht
30/05 ·
Shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDEL
· Persbericht
30/05 ·
Investors who lost money on Inari Medical, Inc.(NARI) should contact Levi & Korsinsky about pending Class Action - NARI
· Persbericht
30/05 ·
Crossject announces publication of clinical data on ZEPIZURE ® in Neurology and Therapy
· Persbericht
29/05 ·
Sarepta Therapeutics Set to Join S&P MidCap 400
· Persbericht
29/05 ·
Medtronic announces pricing of €3.0 billion of senior notes
· Persbericht
29/05 ·
Zimmer Biomet Outlines Strategy to Deliver Above Market Growth at 2024 Investor Day
· Persbericht
29/05 ·
Nanalysis Announces First Quarter 2024 Results
· Persbericht
29/05 ·
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver
· Persbericht
29/05 ·
CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update
· Persbericht
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe